Inflammation

Inflammation-driven autoimmune reactions cause several diseases such as rheumatoid arthritis. The need to alleviate
such reactions as well as autoimmune inflammation in transplantation is significant. Several of the projects in Karolinska
Development’s inflammation portfolio have first-in-class potential.

Inflammation

Concept Development

Lead Discovery

Lead Optimization

Preclinical Development

Phase I

Phase II

Phase III

Launch

NovaSAID AB

ProNoxis AB

NovaSAID AB

NovaSAID is developing new drugs for the treatment of inflammatory diseases, such as rheumatoid arthritis and osteoarthritis.

www.novasaid.se

ProNoxis AB

ProNoxis is developing new small molecules for the treatment of chronic inflammation, such as rheumatoid arthritis, multiple sclerosis and abdominal inflammation.